Publication | Open Access
Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-Mimetics
100
Citations
47
References
2016
Year
Mk2 EnhancesDrug TargetingMedicineMechanism Of ActionAnti-cancer AgentPharmacologyRadiation OncologyNovel TherapyTumor BiologyDrug Discovery
| Year | Citations | |
|---|---|---|
Page 1
Page 1